Norma Spécola

1.1k total citations
19 papers, 376 citations indexed

About

Norma Spécola is a scholar working on Clinical Biochemistry, Physiology and Molecular Biology. According to data from OpenAlex, Norma Spécola has authored 19 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Clinical Biochemistry, 11 papers in Physiology and 9 papers in Molecular Biology. Recurrent topics in Norma Spécola's work include Metabolism and Genetic Disorders (11 papers), Diet and metabolism studies (6 papers) and Lysosomal Storage Disorders Research (5 papers). Norma Spécola is often cited by papers focused on Metabolism and Genetic Disorders (11 papers), Diet and metabolism studies (6 papers) and Lysosomal Storage Disorders Research (5 papers). Norma Spécola collaborates with scholars based in Argentina, Brazil and France. Norma Spécola's co-authors include Jean‐Paul Bonnefont, Anne Lombès, Anne Vassault, Arnold Münnich, H. Ogier, J. B. C. de Klerk, Marion Paturneau-Jouas, Jean Marie Saudubray, Jean Aicardi and J. J. Chevrie and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Norma Spécola

19 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Norma Spécola Argentina 11 206 181 154 61 58 19 376
Pascale Delonlay France 11 255 1.2× 100 0.6× 304 2.0× 33 0.5× 47 0.8× 13 530
Annette S. Feigenbaum Canada 11 387 1.9× 257 1.4× 374 2.4× 87 1.4× 25 0.4× 13 620
Danijela Petković Ramadža Croatia 9 118 0.6× 103 0.6× 134 0.9× 60 1.0× 19 0.3× 26 280
M. E. J. den Boer Netherlands 6 419 2.0× 152 0.8× 346 2.2× 55 0.9× 36 0.6× 7 564
Surekha Pendyal United States 9 158 0.8× 128 0.7× 89 0.6× 214 3.5× 34 0.6× 21 366
F. J. van Spronsen Netherlands 13 410 2.0× 224 1.2× 215 1.4× 77 1.3× 17 0.3× 27 504
Juan Francisco Cabello Chile 11 107 0.5× 126 0.7× 86 0.6× 50 0.8× 12 0.2× 32 287
Mahoko Furujo Japan 10 59 0.3× 130 0.7× 99 0.6× 76 1.2× 71 1.2× 27 319
Darius J. Adams United States 10 328 1.6× 102 0.6× 328 2.1× 64 1.0× 25 0.4× 17 464
Nawal Makhseed Kuwait 12 104 0.5× 53 0.3× 167 1.1× 66 1.1× 23 0.4× 18 303

Countries citing papers authored by Norma Spécola

Since Specialization
Citations

This map shows the geographic impact of Norma Spécola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norma Spécola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norma Spécola more than expected).

Fields of papers citing papers by Norma Spécola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norma Spécola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norma Spécola. The network helps show where Norma Spécola may publish in the future.

Co-authorship network of co-authors of Norma Spécola

This figure shows the co-authorship network connecting the top 25 collaborators of Norma Spécola. A scholar is included among the top collaborators of Norma Spécola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norma Spécola. Norma Spécola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Chiesa, Ana, et al.. (2023). Adherence to PKU guidelines among patients with phenylketonuria: A cross-sectional national multicenter survey-based study in Argentina, Brazil, and Mexico. Molecular Genetics and Metabolism Reports. 38. 101026–101026. 1 indexed citations
2.
Pessoa, André Luiz Santos, Ana María Martins, Erlane Marques Ribeiro, et al.. (2022). Burden of phenylketonuria in Latin American patients: a systematic review and meta-analysis of observational studies. Orphanet Journal of Rare Diseases. 17(1). 302–302. 10 indexed citations
3.
Pessoa, André Luiz Santos, Ana María Martins, Erlane Marques Ribeiro, et al.. (2022). Burden of phenylketonuria in Latin American patients: A systematic review and meta-analysis of observational studies. Research Square. 3 indexed citations
4.
Guelbert, Norberto, et al.. (2020). Position of Experts Regarding Follow-Up of Patients with Neuronal Ceroid Lipofuscinosis-2 Disease in Latin America. SHILAP Revista de lepidopterología. 8. 1 indexed citations
5.
Lourenço, Charles Marques, André Luiz Santos Pessoa, M. Troncoso, et al.. (2020). Revealing the clinical phenotype of atypical neuronal ceroid lipofuscinosis type 2 disease: Insights from the largest cohort in the world. Journal of Paediatrics and Child Health. 57(4). 519–525. 15 indexed citations
6.
Maxit, Clarisa, et al.. (2019). Infantile-onset Pompe disease: Diagnosis and management. Archivos Argentinos de Pediatria. 117(4). 271–278. 20 indexed citations
7.
Santos‐Simarro, Fernando, et al.. (2019). Phenylalanine Hydroxylase (PAH) Genotyping in PKU Argentine Patients. SHILAP Revista de lepidopterología. 7. 8 indexed citations
8.
Cohen, Leila, Dolores González‐Morón, Hernán Amartino, et al.. (2019). Argentinian clinical genomics in a leukodystrophies and genetic leukoencephalopathies cohort: Diagnostic yield in our first 9 years. Annals of Human Genetics. 84(1). 11–28. 6 indexed citations
9.
Spécola, Norma & Ana Chiesa. (2017). Alternative Therapies for PKU. SHILAP Revista de lepidopterología. 5. 4078080733–4078080733. 8 indexed citations
10.
Amartino, Hernán, et al.. (2014). Identification of 17 novel mutations in 40 Argentinean unrelated families with mucopolysaccharidosis type II (Hunter syndrome). Molecular Genetics and Metabolism Reports. 1. 401–406. 9 indexed citations
11.
Pérez, Belén, Rocío Sánchez-Alcudia, B. Merinero, et al.. (2010). The molecular landscape of propionic acidemia and methylmalonic aciduria in Latin America. Journal of Inherited Metabolic Disease. 33(S2). 307–314. 14 indexed citations
12.
Abdenur, José E., et al.. (2005). Aromatic l-aminoacid decarboxylase deficiency: Unusual neonatal presentation and additional findings in organic acid analysis. Molecular Genetics and Metabolism. 87(1). 48–53. 29 indexed citations
13.
Spécola, Norma, et al.. (1999). MCAD deficiency. Acylcarnitines (AC) by tandem mass spectrometry (MS-MS) are useful to monitor dietary treatment.. PubMed. 466. 353–63. 2 indexed citations
14.
Meırleır, Linda De, Norma Spécola, Sara Seneca, & Willy Lissens. (1998). Pyruvate dehydrogenase E1α deficiency in a family: Different clinical presentation in two siblings. Journal of Inherited Metabolic Disease. 21(3). 224–226. 10 indexed citations
15.
Bonnefont, Jean‐Paul, Norma Spécola, Anne Vassault, et al.. (1990). The fasting test in paediatrics: Application to the diagnosis of pathological hypo- and hyperketotic states. European Journal of Pediatrics. 150(2). 80–85. 109 indexed citations
16.
Spécola, Norma, et al.. (1990). The juvenile and chronic forms of GM 2 gangliosidosis. Neurology. 40(1). 145–145. 31 indexed citations
17.
Saudubray, J. M., H. Ogier, Jean‐Paul Bonnefont, et al.. (1989). Clinical approach to inherited metabolic diseases in the neonatal period: A 20‐year survey. Journal of Inherited Metabolic Disease. 12(S1). 25–41. 38 indexed citations
18.
Chevrie, J. J., Norma Spécola, & Jean Aicardi. (1988). Secondary bilateral synchrony in unilateral pial angiomatosis: successful surgical treatment.. Journal of Neurology Neurosurgery & Psychiatry. 51(5). 663–670. 20 indexed citations
19.
Spécola, Norma, B. Middleton, Anne Lombès, et al.. (1987). Hyperketotic States Due to Inherited Defects of Ketolysis. Enzyme. 38(1-4). 80–90. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026